InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
19
T+90 hit rate
56%
T+90 mean return
-0.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by ROBINS CHAD M, Chief Executive Officer. Insider active across 1 company, notably Adaptive Biotechnologies Corp. Cumulatively, 28 disclosures have been published. Split: 0 buy · 19 sells. Total volume traded: €21.3m. History available since 15 June 2021. The latest transaction was filed on 6 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations28 total
83,332 shares@ US$14.410.047% mcap5.9% of flowCommon StockSEC:0001780649-26-000011
83,332 shares@ US$14.410.051% mcap5.9% of flowCommon StockSEC:0001780649-26-000011:0
182,891 shares@ US$15.9914.1% of flowCommon StockSEC:0001780649-26-000003
182,891 shares@ US$15.990.12% mcap14.1% of flowCommon StockSEC:0001780649-26-000003:0
124,998 shares@ US$18.440.095% mcap11.0% of flowCommon StockSEC:0001780649-26-000002:0
124,998 shares@ US$18.4411.0% of flowCommon StockSEC:0001780649-26-000002
124,998 shares@ US$15.599.4% of flowCommon StockSEC:0001780649-26-000001
124,998 shares@ US$15.590.081% mcap9.4% of flowCommon StockSEC:0001780649-26-000001:0
35,736 shares@ US$19.683.5% of flowCommon StockSEC:0001780649-25-000003
35,736 shares@ US$19.680.030% mcap3.5% of flowCommon StockSEC:0001780649-25-000003:0
355,000 shares0Common StockSEC:0001062993-25-004809:0
186,080 shares@ US$6.324.4% of flowCommon StockSEC:0001062993-25-003241:0
100,287 shares@ US$6.322.4% of flowCommon StockSEC:0001062993-25-002744:0
100,287 shares@ US$8.443.2% of flowCommon StockSEC:0001062993-25-002744:1
158,921 shares@ US$6.323.8% of flowCommon StockSEC:0001062993-25-002744:2
158,921 shares@ US$8.465.1% of flowCommon StockSEC:0001062993-25-002744:3
211,160 shares@ US$6.325.0% of flowCommon StockSEC:0001062993-25-002744:4
211,160 shares@ US$8.506.7% of flowCommon StockSEC:0001062993-25-002744:5
354,610 shares0Common StockSEC:0001062993-24-005758:0
354,610 shares0Common StockSEC:0001062993-23-006321:0
14,815 shares@ US$6.320.0042% mcap0.5% of flowCommon StockSEC:0001209191-22-017696:0
247,117 shares0Common StockSEC:0001209191-22-017393:0
11,742 shares@ US$38.340.019% mcap2.2% of flowCommon StockSEC:0001209191-21-055586:0
11,742 shares@ US$38.340.019% mcap4.3% of flowCommon StockSEC:0001209191-21-055586
1,501 shares@ US$38.240.0024% mcap0.3% of flowCommon StockSEC:0001209191-21-046710:0
25 of 28 declarations
About ROBINS CHAD M
Chad M. Robins is the Chief Executive Officer of Adaptive Biotechnologies Corp.
